Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|April 13, 2011
Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patientsJoanne S L Lim, Xiang A Chen, Onkar Singh, et al.
Frontiers in Pharmacology|September 29, 2017
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with TamoxifenWerner Schroth, Stefan Winter, Thomas Mürdter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2016
EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC PatientsNatalia Sutiman, Shao Weng Tan, Eng Huat Tan, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 20, 2022
Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in SingaporeJia Qi Yeo, Hua Heng McVin Cheen, Amanda Wong, et al.
Pharmacogenetics and Genomics|August 15, 2006
Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patientsXiaoqiang Xiang, Srinivasa Rao Jada, Hui Hua Li, et al.
Pageof 9